NCT04666129 Study of Relugolix in Men With Metastatic Castration-Sensitive Prostate Cancer or Non-Metastatic or Metastatic Castration-Resistant Prostate Cancer Status COMPLETED Phase PHASE1
NCT04662580 ARX517/JNJ-95298177 as Monotherapy or Combination Therapy in Subjects With Metastatic Prostate Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT04660799 A Study on Pharmacokinetics (PK), Efficacy and Safety of Subcutaneous (SC) Versus Intravenous (IV) Rituximab, in Combination With CHOP (Cyclophosphamide, Doxorubicin, Vincristine, Prednisone) in Previously Untreated Participants With CD20 Positive Diffuse Large B-Cell Lymphoma (DLBCL) Status COMPLETED Phase PHASE2
NCT04654988 Study to Evaluate the Efficacy of Immunosuppression in Myocarditis or Inflammatory Cardiomyopathy. Status RECRUITING Phase PHASE4
NCT04633252 A Phase I/II Study of PDS01ADC With Docetaxel and Abiraterone in Adults With Metastatic Castration Sensitive and PDS01ADC With Docetaxel in Castration Resistant Prostate Cancer Status RECRUITING Phase PHASE1/PHASE2
NCT04628988 A Study of CC-90011 and Comparators in Participants With Prostate Cancer Status COMPLETED Phase PHASE1
NCT04626791 Modified VR-CAP and Acalabrutinib as First Line Therapy for the Treatment of Transplant-Eligible Patients With Mantle Cell Lymphoma Status RECRUITING Phase PHASE2
NCT04598477 A Study to Assess the Long-term Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod PH20 SC in Adults With Pemphigus (Vulgaris or Foliaceus) Status TERMINATED Phase PHASE3
NCT04598451 A Study to Assess the Efficacy and Safety of a Subcutaneous Formulation of Efgartigimod PH20 SC in Adults With Pemphigus (Vulgaris or Foliaceus) Status COMPLETED Phase PHASE3
NCT04594798 A Study of Polatuzumab Vedotin, Rituximab and Dose Attenuated CHP in Older Patients With DLBCL Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04577833 A Study of Comparative Formulations of Niraparib and Abiraterone Acetate (AA) in Men With Prostate Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT04569032 A Study of Brentuximab Vedotin and CHP in Frontline Treatment of PTCL With Less Than 10% CD30 Expression Status COMPLETED Phase PHASE2
NCT04558268 Low Dose Prednisone Therapy in Women With Recurrent Pregnancy Loss Status UNKNOWN Phase PHASE2/PHASE3
NCT04556617 PLX2853 in Combination With Abiraterone Acetate and Prednisone and in Combination With Olaparib in Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC) Status TERMINATED Phase PHASE1/PHASE2
NCT04536662 Comparisons of Different Forms of Glucocorticoid on the Recovery of Reproductive Function in Patients With 21α-hydroxylase Deficiency Status UNKNOWN Phase PHASE4
NCT04534478 Oral Prednisone Regimens to Optimize the Therapeutic Strategy in Patients With Organizing Pneumonia Post-COVID-19 Status UNKNOWN Phase PHASE4